Helicobacter pylori CagA Interacts with SHP-1 to Suppress the Immune Response by Targeting TRAF6 for K63-Linked Ubiquitination.
Huan HeJing LiuLiuyan LiGui QianDoudou HaoManman LiYihua ZhangXiaowu HongJianqing XuDapeng YanPublished in: Journal of immunology (Baltimore, Md. : 1950) (2021)
Helicobacter pylori is the major etiological agent for most gastric cancer. CagA has been reported to be an important virulence factor of H. pylori, but its effect on the immune response is not yet clear. In this study, wild-type C57BL/6 mice and Ptpn6me-v/me-v mice were randomly assigned for infection with H. pylori We demonstrated that CagA suppressed H. pylori-stimulated expression of proinflammatory cytokines in vivo. Besides, we infected mouse peritoneal macrophages RAW264.7 and AGS with H. pylori Our results showed that CagA suppressed expression of proinflammatory cytokines through inhibiting the MAPKs and NF-κB pathways activation in vitro. Mechanistically, we found that CagA interacted with the host cellular tyrosine phosphatase SHP-1, which facilitated the recruitment of SHP-1 to TRAF6 and inhibited the K63-linked ubiquitination of TRAF6, which obstructed the transmission of signal downstream. Taken together, these findings reveal a previously unknown mechanism by which CagA negatively regulates the posttranslational modification of TRAF6 in innate antibacterial immune response and provide molecular basis for new therapeutics to treat microbial infection.
Keyphrases
- helicobacter pylori
- immune response
- wild type
- helicobacter pylori infection
- poor prognosis
- dendritic cells
- signaling pathway
- toll like receptor
- escherichia coli
- staphylococcus aureus
- binding protein
- pseudomonas aeruginosa
- microbial community
- high fat diet induced
- oxidative stress
- adipose tissue
- antimicrobial resistance
- nuclear factor